Lesser-known cannabinoids showed stronger anti-inflammatory effects when combined with other cannabis plant compounds

All ten tested non-psychoactive phytocannabinoids demonstrated anti-inflammatory effects. CBDV was particularly effective, reducing IL-6, TNF-alpha, and inhibiting NF-kB activation. Acidic cannabinoid forms showed high antioxidant capacity (ORAC) but limited cellular antioxidant activity. Combinations containing CBG or CBN with cannabis plant matrices showed particularly potent synergistic anti-inflammatory effects.

Anti-inflammatory effects of ten major non-psychotropic phytocannabinoids were tested in macrophage-differentiated THP-1 cells by measuring pro-inflammatory cytokines (ELISA) and NF-kB activation (luciferase reporter). Antioxidant activity was assessed by ORAC and cellular antioxidant activity assays. Synergy was tested with three cannabis-derived matrices (polar, non-polar, terpenoid).

Most cannabis research focuses on CBD and THC, but this study systematically compares ten cannabinoids and shows that lesser-known compounds like CBDV, CBG, and CBN may be more effective for inflammation, especially in combination with other plant compounds.

This study provides systematic evidence for the "entourage effect" theory, showing that cannabinoids combined with other cannabis plant fractions can produce effects greater than either alone, supporting the therapeutic potential of full-spectrum preparations.

In vitro study using cell lines, not human subjects. The synergistic effects observed in cells may not translate to oral consumption. Non-polar and terpenoid matrices are complex mixtures making it difficult to identify specific synergy drivers.